Key result
Pharmacological and mechanical treatments, including novel agents and devices, have significantly advanced the management of heart failure, though challenges remain in treating specific subtypes like HFpEF.
Why the study?
Heart failure causes considerable morbidity, hospitalization, and mortality, while notable advances in definition, diagnosis, and treatment have led to newly developed agents and devices widely adopted in practice.
This review summarizes current pharmacological and device-based therapies for heart failure and highlights gaps in current research.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2020) conducted a review in Heart failure. Pharmacological and mechanical treatments was evaluated. Pharmacological and mechanical treatments, including novel agents and devices, have significantly advanced the management of heart failure, though challenges remain in treating specific subtypes like HFpEF.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: